Afamitresgene autoleucel
id:
afamitresgene-autoleucel-163-3635421
title:
Afamitresgene autoleucel
text:
Afamitresgene autoleucel, sold under the brand name Tecelra is a T cell immunotherapy used for the treatment of synovial sarcoma. It is a T cell receptor (TCR) gene therapy. It is administered as a single intravenous dose. The most common adverse reactions include cytokine release syndrome, nausea, vomiting, fatigue, infections, pyrexia, constipation, dyspnea, abdominal pain, non-cardiac chest pain, decreased appetite, tachycardia, back pain, hypotension, diarrhea, and edema. Afamitresgene autol
brand slug:
wiki
category slug:
encyclopedia
description:
Medication
original url:
https://en.wikipedia.org/wiki/Afamitresgene_autoleucel
date created:
2024-08-05T03:55:59Z
date modified:
2024-08-28T06:10:14Z
main entity:
{"identifier":"Q129322330","url":"https://www.wikidata.org/entity/Q129322330"}
image:
fields total:
13
integrity:
15